Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
CYBERDYNE ( (JP:7779) ) has provided an update.
CYBERDYNE Inc. announced its Shareholder Benefit Program for FY2025, which offers shareholders discounts on the Neuro HALFIT programs. These programs aim to enhance physical functions for those with disabilities, reflecting the company’s commitment to societal health and welfare. The program runs from June 2025 to May 2026, allowing shareholders to choose between at-home or private center-based Neuro HALFIT options, with discounts varying based on the number of shares held.
More about CYBERDYNE
CYBERDYNE Inc. operates in the healthcare industry and is known for its innovative solutions, including the Wearable Cyborg HAL, which is designed to improve the brain-nerve-musculoskeletal function. The company focuses on enabling individuals with physical disabilities to engage in social activities, supporting its mission of ‘Health and Welfare for All.’
YTD Price Performance: -6.32%
Average Trading Volume: 1,000
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $253.8M
See more insights into 7779 stock on TipRanks’ Stock Analysis page.
